カテゴリー： 世界, 医療/バイオ, LP Information

世界の急性骨髄性白血病バイオマーカー検出市場予測 2023年-2029年

【英語タイトル】Global Acute Myeloid Leukemia Biomarker Detection Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC10924）・商品コード：LP23DC10924
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：105
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥549,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥823,500見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,098,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の急性骨髄性白血病バイオマーカー検出市場」は、過去の販売実績から2022年の世界の急性骨髄性白血病バイオマーカー検出の総販売量を検討し、2023年から2029年の予測される急性骨髄性白血病バイオマーカー検出の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の急性骨髄性白血病バイオマーカー検出の市場規模を掲載し、XXX百万米ドル規模の世界の急性骨髄性白血病バイオマーカー検出市場の詳細な分析を提供します。本インサイトレポートは、世界の急性骨髄性白血病バイオマーカー検出業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の急性骨髄性白血病バイオマーカー検出市場における各社の独自のポジションをより深く理解するために、急性骨髄性白血病バイオマーカー検出製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の急性骨髄性白血病バイオマーカー検出市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。急性骨髄性白血病バイオマーカー検出の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。急性骨髄性白血病バイオマーカー検出の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。急性骨髄性白血病バイオマーカー検出のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

急性骨髄性白血病バイオマーカー検出の世界主要メーカーとしては、Abbott Laboratories、 Bio-Rad Laboratories, Inc.、 Genmark Saghlk Orinleri、 Laboratory Corporation of America Holdings、 Danaher、 Medaysis Company、 NeoGenomics Laboratories、 QIAGEN N.V.、 Thermo Fisher Scientific, Inc.、 GeneTexなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の急性骨髄性白血病バイオマーカー検出市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では急性骨髄性白血病バイオマーカー検出市場をセグメンテーションし、種類別 (次世代シーケンス技術、PCR検出技術)、用途別 (病院、研究機関、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：次世代シーケンス技術、PCR検出技術

・用途別区分：病院、研究機関、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の急性骨髄性白血病バイオマーカー検出市場の10年間の市場状況・展望は？
・世界および地域別に見た急性骨髄性白血病バイオマーカー検出市場成長の要因は何か？
・急性骨髄性白血病バイオマーカー検出の市場機会はエンドマーケットの規模によってどのように変化するのか？
・急性骨髄性白血病バイオマーカー検出のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：急性骨髄性白血病バイオマーカー検出の年間販売量2018-2029、地域別現状・将来分析
・急性骨髄性白血病バイオマーカー検出の種類別セグメント：次世代シーケンス技術、PCR検出技術
・急性骨髄性白血病バイオマーカー検出の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・急性骨髄性白血病バイオマーカー検出の用途別セグメント：病院、研究機関、その他
・急性骨髄性白血病バイオマーカー検出の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の急性骨髄性白血病バイオマーカー検出市場
・企業別のグローバル急性骨髄性白血病バイオマーカー検出市場データ：2018-2023年の年間販売量、市場シェア
・企業別の急性骨髄性白血病バイオマーカー検出の年間売上：2018-2023年の売上、市場シェア
・企業別の急性骨髄性白血病バイオマーカー検出販売価格
・主要企業の急性骨髄性白血病バイオマーカー検出生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

急性骨髄性白血病バイオマーカー検出の地域別レビュー
・地域別の急性骨髄性白血病バイオマーカー検出市場規模2018-2023：年間販売量、売上
・主要国別の急性骨髄性白血病バイオマーカー検出市場規模2018-2023：年間販売量、売上
・南北アメリカの急性骨髄性白血病バイオマーカー検出販売の成長
・アジア太平洋の急性骨髄性白血病バイオマーカー検出販売の成長
・ヨーロッパの急性骨髄性白血病バイオマーカー検出販売の成長
・中東・アフリカの急性骨髄性白血病バイオマーカー検出販売の成長

南北アメリカ市場
・南北アメリカの国別の急性骨髄性白血病バイオマーカー検出販売量、売上（2018-2023）
・南北アメリカの急性骨髄性白血病バイオマーカー検出の種類別販売量
・南北アメリカの急性骨髄性白血病バイオマーカー検出の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の急性骨髄性白血病バイオマーカー検出販売量、売上（2018-2023）
・アジア太平洋の急性骨髄性白血病バイオマーカー検出の種類別販売量
・アジア太平洋の急性骨髄性白血病バイオマーカー検出の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の急性骨髄性白血病バイオマーカー検出販売量、売上（2018-2023）
・ヨーロッパの急性骨髄性白血病バイオマーカー検出の種類別販売量
・ヨーロッパの急性骨髄性白血病バイオマーカー検出の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の急性骨髄性白血病バイオマーカー検出販売量、売上（2018-2023）
・中東・アフリカの急性骨髄性白血病バイオマーカー検出の種類別販売量
・中東・アフリカの急性骨髄性白血病バイオマーカー検出の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・急性骨髄性白血病バイオマーカー検出の製造コスト構造分析
・急性骨髄性白血病バイオマーカー検出の製造プロセス分析
・急性骨髄性白血病バイオマーカー検出の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・急性骨髄性白血病バイオマーカー検出の主要なグローバル販売業者
・急性骨髄性白血病バイオマーカー検出の主要なグローバル顧客

地域別の急性骨髄性白血病バイオマーカー検出市場予測レビュー
・地域別の急性骨髄性白血病バイオマーカー検出市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・急性骨髄性白血病バイオマーカー検出の種類別市場規模予測
・急性骨髄性白血病バイオマーカー検出の用途別市場規模予測

主要企業分析
Abbott Laboratories、 Bio-Rad Laboratories, Inc.、 Genmark Saghlk Orinleri、 Laboratory Corporation of America Holdings、 Danaher、 Medaysis Company、 NeoGenomics Laboratories、 QIAGEN N.V.、 Thermo Fisher Scientific, Inc.、 GeneTex
・企業情報
・急性骨髄性白血病バイオマーカー検出製品
・急性骨髄性白血病バイオマーカー検出販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Acute Myeloid Leukemia Biomarker Detection market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Acute Myeloid Leukemia Biomarker Detection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Acute Myeloid Leukemia Biomarker Detection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Acute Myeloid Leukemia Biomarker Detection is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Acute Myeloid Leukemia Biomarker Detection players cover Abbott Laboratories, Bio-Rad Laboratories, Inc., Genmark Saghlk Orinleri, Laboratory Corporation of America Holdings, Danaher, Medaysis Company, NeoGenomics Laboratories, QIAGEN N.V. and Thermo Fisher Scientific, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Acute myeloid leukemia is a malignant neoplastic disease that usually results from the deterioration of stem cells in the bone marrow. Biomarker detection is a method that can detect specific molecular or genetic variations of leukemia cells, which can be used to diagnose AML, evaluate patient prognosis, and guide the selection of treatment options.
LPI (LP Information)’ newest research report, the “Acute Myeloid Leukemia Biomarker Detection Industry Forecast” looks at past sales and reviews total world Acute Myeloid Leukemia Biomarker Detection sales in 2022, providing a comprehensive analysis by region and market sector of projected Acute Myeloid Leukemia Biomarker Detection sales for 2023 through 2029. With Acute Myeloid Leukemia Biomarker Detection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Acute Myeloid Leukemia Biomarker Detection industry.
This Insight Report provides a comprehensive analysis of the global Acute Myeloid Leukemia Biomarker Detection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Acute Myeloid Leukemia Biomarker Detection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Acute Myeloid Leukemia Biomarker Detection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Acute Myeloid Leukemia Biomarker Detection and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Acute Myeloid Leukemia Biomarker Detection.
This report presents a comprehensive overview, market shares, and growth opportunities of Acute Myeloid Leukemia Biomarker Detection market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Next Generation Sequencing Technology
PCR Detection Technology
Segmentation by application
Hospital
Research Institutions
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Abbott Laboratories
Bio-Rad Laboratories, Inc.
Genmark Saghlk Orinleri
Laboratory Corporation of America Holdings
Danaher
Medaysis Company
NeoGenomics Laboratories
QIAGEN N.V.
Thermo Fisher Scientific, Inc.
GeneTex
Key Questions Addressed in this Report
What is the 10-year outlook for the global Acute Myeloid Leukemia Biomarker Detection market?
What factors are driving Acute Myeloid Leukemia Biomarker Detection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Acute Myeloid Leukemia Biomarker Detection market opportunities vary by end market size?
How does Acute Myeloid Leukemia Biomarker Detection break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Acute Myeloid Leukemia Biomarker Detection Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Acute Myeloid Leukemia Biomarker Detection by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Acute Myeloid Leukemia Biomarker Detection by Country/Region, 2018, 2022 & 2029
2.2 Acute Myeloid Leukemia Biomarker Detection Segment by Type
2.2.1 Next Generation Sequencing Technology
2.2.2 PCR Detection Technology
2.3 Acute Myeloid Leukemia Biomarker Detection Sales by Type
2.3.1 Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Type (2018-2023)
2.3.2 Global Acute Myeloid Leukemia Biomarker Detection Revenue and Market Share by Type (2018-2023)
2.3.3 Global Acute Myeloid Leukemia Biomarker Detection Sale Price by Type (2018-2023)
2.4 Acute Myeloid Leukemia Biomarker Detection Segment by Application
2.4.1 Hospital
2.4.2 Research Institutions
2.4.3 Other
2.5 Acute Myeloid Leukemia Biomarker Detection Sales by Application
2.5.1 Global Acute Myeloid Leukemia Biomarker Detection Sale Market Share by Application (2018-2023)
2.5.2 Global Acute Myeloid Leukemia Biomarker Detection Revenue and Market Share by Application (2018-2023)
2.5.3 Global Acute Myeloid Leukemia Biomarker Detection Sale Price by Application (2018-2023)
3 Global Acute Myeloid Leukemia Biomarker Detection by Company
3.1 Global Acute Myeloid Leukemia Biomarker Detection Breakdown Data by Company
3.1.1 Global Acute Myeloid Leukemia Biomarker Detection Annual Sales by Company (2018-2023)
3.1.2 Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Company (2018-2023)
3.2 Global Acute Myeloid Leukemia Biomarker Detection Annual Revenue by Company (2018-2023)
3.2.1 Global Acute Myeloid Leukemia Biomarker Detection Revenue by Company (2018-2023)
3.2.2 Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Company (2018-2023)
3.3 Global Acute Myeloid Leukemia Biomarker Detection Sale Price by Company
3.4 Key Manufacturers Acute Myeloid Leukemia Biomarker Detection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Acute Myeloid Leukemia Biomarker Detection Product Location Distribution
3.4.2 Players Acute Myeloid Leukemia Biomarker Detection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Acute Myeloid Leukemia Biomarker Detection by Geographic Region
4.1 World Historic Acute Myeloid Leukemia Biomarker Detection Market Size by Geographic Region (2018-2023)
4.1.1 Global Acute Myeloid Leukemia Biomarker Detection Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Acute Myeloid Leukemia Biomarker Detection Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Acute Myeloid Leukemia Biomarker Detection Market Size by Country/Region (2018-2023)
4.2.1 Global Acute Myeloid Leukemia Biomarker Detection Annual Sales by Country/Region (2018-2023)
4.2.2 Global Acute Myeloid Leukemia Biomarker Detection Annual Revenue by Country/Region (2018-2023)
4.3 Americas Acute Myeloid Leukemia Biomarker Detection Sales Growth
4.4 APAC Acute Myeloid Leukemia Biomarker Detection Sales Growth
4.5 Europe Acute Myeloid Leukemia Biomarker Detection Sales Growth
4.6 Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales Growth
5 Americas
5.1 Americas Acute Myeloid Leukemia Biomarker Detection Sales by Country
5.1.1 Americas Acute Myeloid Leukemia Biomarker Detection Sales by Country (2018-2023)
5.1.2 Americas Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2018-2023)
5.2 Americas Acute Myeloid Leukemia Biomarker Detection Sales by Type
5.3 Americas Acute Myeloid Leukemia Biomarker Detection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Acute Myeloid Leukemia Biomarker Detection Sales by Region
6.1.1 APAC Acute Myeloid Leukemia Biomarker Detection Sales by Region (2018-2023)
6.1.2 APAC Acute Myeloid Leukemia Biomarker Detection Revenue by Region (2018-2023)
6.2 APAC Acute Myeloid Leukemia Biomarker Detection Sales by Type
6.3 APAC Acute Myeloid Leukemia Biomarker Detection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Acute Myeloid Leukemia Biomarker Detection by Country
7.1.1 Europe Acute Myeloid Leukemia Biomarker Detection Sales by Country (2018-2023)
7.1.2 Europe Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2018-2023)
7.2 Europe Acute Myeloid Leukemia Biomarker Detection Sales by Type
7.3 Europe Acute Myeloid Leukemia Biomarker Detection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Acute Myeloid Leukemia Biomarker Detection by Country
8.1.1 Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales by Country (2018-2023)
8.1.2 Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2018-2023)
8.2 Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales by Type
8.3 Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Acute Myeloid Leukemia Biomarker Detection
10.3 Manufacturing Process Analysis of Acute Myeloid Leukemia Biomarker Detection
10.4 Industry Chain Structure of Acute Myeloid Leukemia Biomarker Detection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Acute Myeloid Leukemia Biomarker Detection Distributors
11.3 Acute Myeloid Leukemia Biomarker Detection Customer
12 World Forecast Review for Acute Myeloid Leukemia Biomarker Detection by Geographic Region
12.1 Global Acute Myeloid Leukemia Biomarker Detection Market Size Forecast by Region
12.1.1 Global Acute Myeloid Leukemia Biomarker Detection Forecast by Region (2024-2029)
12.1.2 Global Acute Myeloid Leukemia Biomarker Detection Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Acute Myeloid Leukemia Biomarker Detection Forecast by Type
12.7 Global Acute Myeloid Leukemia Biomarker Detection Forecast by Application
13 Key Players Analysis
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Information
13.1.2 Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
13.1.3 Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abbott Laboratories Main Business Overview
13.1.5 Abbott Laboratories Latest Developments
13.2 Bio-Rad Laboratories, Inc.
13.2.1 Bio-Rad Laboratories, Inc. Company Information
13.2.2 Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
13.2.3 Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Bio-Rad Laboratories, Inc. Main Business Overview
13.2.5 Bio-Rad Laboratories, Inc. Latest Developments
13.3 Genmark Saghlk Orinleri
13.3.1 Genmark Saghlk Orinleri Company Information
13.3.2 Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
13.3.3 Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Genmark Saghlk Orinleri Main Business Overview
13.3.5 Genmark Saghlk Orinleri Latest Developments
13.4 Laboratory Corporation of America Holdings
13.4.1 Laboratory Corporation of America Holdings Company Information
13.4.2 Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
13.4.3 Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Laboratory Corporation of America Holdings Main Business Overview
13.4.5 Laboratory Corporation of America Holdings Latest Developments
13.5 Danaher
13.5.1 Danaher Company Information
13.5.2 Danaher Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
13.5.3 Danaher Acute Myeloid Leukemia Biomarker Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Danaher Main Business Overview
13.5.5 Danaher Latest Developments
13.6 Medaysis Company
13.6.1 Medaysis Company Company Information
13.6.2 Medaysis Company Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
13.6.3 Medaysis Company Acute Myeloid Leukemia Biomarker Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Medaysis Company Main Business Overview
13.6.5 Medaysis Company Latest Developments
13.7 NeoGenomics Laboratories
13.7.1 NeoGenomics Laboratories Company Information
13.7.2 NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
13.7.3 NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 NeoGenomics Laboratories Main Business Overview
13.7.5 NeoGenomics Laboratories Latest Developments
13.8 QIAGEN N.V.
13.8.1 QIAGEN N.V. Company Information
13.8.2 QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
13.8.3 QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 QIAGEN N.V. Main Business Overview
13.8.5 QIAGEN N.V. Latest Developments
13.9 Thermo Fisher Scientific, Inc.
13.9.1 Thermo Fisher Scientific, Inc. Company Information
13.9.2 Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
13.9.3 Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Thermo Fisher Scientific, Inc. Main Business Overview
13.9.5 Thermo Fisher Scientific, Inc. Latest Developments
13.10 GeneTex
13.10.1 GeneTex Company Information
13.10.2 GeneTex Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
13.10.3 GeneTex Acute Myeloid Leukemia Biomarker Detection Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 GeneTex Main Business Overview
13.10.5 GeneTex Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Acute Myeloid Leukemia Biomarker Detection Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Acute Myeloid Leukemia Biomarker Detection Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Next Generation Sequencing Technology
Table 4. Major Players of PCR Detection Technology
Table 5. Global Acute Myeloid Leukemia Biomarker Detection Sales by Type (2018-2023) & (K Units)
Table 6. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Type (2018-2023)
Table 7. Global Acute Myeloid Leukemia Biomarker Detection Revenue by Type (2018-2023) & ($ million)
Table 8. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Type (2018-2023)
Table 9. Global Acute Myeloid Leukemia Biomarker Detection Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Acute Myeloid Leukemia Biomarker Detection Sales by Application (2018-2023) & (K Units)
Table 11. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Application (2018-2023)
Table 12. Global Acute Myeloid Leukemia Biomarker Detection Revenue by Application (2018-2023)
Table 13. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Application (2018-2023)
Table 14. Global Acute Myeloid Leukemia Biomarker Detection Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Acute Myeloid Leukemia Biomarker Detection Sales by Company (2018-2023) & (K Units)
Table 16. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Company (2018-2023)
Table 17. Global Acute Myeloid Leukemia Biomarker Detection Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Company (2018-2023)
Table 19. Global Acute Myeloid Leukemia Biomarker Detection Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Acute Myeloid Leukemia Biomarker Detection Producing Area Distribution and Sales Area
Table 21. Players Acute Myeloid Leukemia Biomarker Detection Products Offered
Table 22. Acute Myeloid Leukemia Biomarker Detection Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Acute Myeloid Leukemia Biomarker Detection Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share Geographic Region (2018-2023)
Table 27. Global Acute Myeloid Leukemia Biomarker Detection Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Acute Myeloid Leukemia Biomarker Detection Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Country/Region (2018-2023)
Table 31. Global Acute Myeloid Leukemia Biomarker Detection Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Acute Myeloid Leukemia Biomarker Detection Sales by Country (2018-2023) & (K Units)
Table 34. Americas Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Country (2018-2023)
Table 35. Americas Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Country (2018-2023)
Table 37. Americas Acute Myeloid Leukemia Biomarker Detection Sales by Type (2018-2023) & (K Units)
Table 38. Americas Acute Myeloid Leukemia Biomarker Detection Sales by Application (2018-2023) & (K Units)
Table 39. APAC Acute Myeloid Leukemia Biomarker Detection Sales by Region (2018-2023) & (K Units)
Table 40. APAC Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Region (2018-2023)
Table 41. APAC Acute Myeloid Leukemia Biomarker Detection Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Region (2018-2023)
Table 43. APAC Acute Myeloid Leukemia Biomarker Detection Sales by Type (2018-2023) & (K Units)
Table 44. APAC Acute Myeloid Leukemia Biomarker Detection Sales by Application (2018-2023) & (K Units)
Table 45. Europe Acute Myeloid Leukemia Biomarker Detection Sales by Country (2018-2023) & (K Units)
Table 46. Europe Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Country (2018-2023)
Table 47. Europe Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Country (2018-2023)
Table 49. Europe Acute Myeloid Leukemia Biomarker Detection Sales by Type (2018-2023) & (K Units)
Table 50. Europe Acute Myeloid Leukemia Biomarker Detection Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Acute Myeloid Leukemia Biomarker Detection
Table 58. Key Market Challenges & Risks of Acute Myeloid Leukemia Biomarker Detection
Table 59. Key Industry Trends of Acute Myeloid Leukemia Biomarker Detection
Table 60. Acute Myeloid Leukemia Biomarker Detection Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Acute Myeloid Leukemia Biomarker Detection Distributors List
Table 63. Acute Myeloid Leukemia Biomarker Detection Customer List
Table 64. Global Acute Myeloid Leukemia Biomarker Detection Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Acute Myeloid Leukemia Biomarker Detection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Acute Myeloid Leukemia Biomarker Detection Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Acute Myeloid Leukemia Biomarker Detection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Acute Myeloid Leukemia Biomarker Detection Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Acute Myeloid Leukemia Biomarker Detection Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Acute Myeloid Leukemia Biomarker Detection Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Acute Myeloid Leukemia Biomarker Detection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Acute Myeloid Leukemia Biomarker Detection Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Acute Myeloid Leukemia Biomarker Detection Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Acute Myeloid Leukemia Biomarker Detection Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Acute Myeloid Leukemia Biomarker Detection Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Abbott Laboratories Basic Information, Acute Myeloid Leukemia Biomarker Detection Manufacturing Base, Sales Area and Its Competitors
Table 79. Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
Table 80. Abbott Laboratories Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Abbott Laboratories Main Business
Table 82. Abbott Laboratories Latest Developments
Table 83. Bio-Rad Laboratories, Inc. Basic Information, Acute Myeloid Leukemia Biomarker Detection Manufacturing Base, Sales Area and Its Competitors
Table 84. Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
Table 85. Bio-Rad Laboratories, Inc. Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Bio-Rad Laboratories, Inc. Main Business
Table 87. Bio-Rad Laboratories, Inc. Latest Developments
Table 88. Genmark Saghlk Orinleri Basic Information, Acute Myeloid Leukemia Biomarker Detection Manufacturing Base, Sales Area and Its Competitors
Table 89. Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
Table 90. Genmark Saghlk Orinleri Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Genmark Saghlk Orinleri Main Business
Table 92. Genmark Saghlk Orinleri Latest Developments
Table 93. Laboratory Corporation of America Holdings Basic Information, Acute Myeloid Leukemia Biomarker Detection Manufacturing Base, Sales Area and Its Competitors
Table 94. Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
Table 95. Laboratory Corporation of America Holdings Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Laboratory Corporation of America Holdings Main Business
Table 97. Laboratory Corporation of America Holdings Latest Developments
Table 98. Danaher Basic Information, Acute Myeloid Leukemia Biomarker Detection Manufacturing Base, Sales Area and Its Competitors
Table 99. Danaher Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
Table 100. Danaher Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Danaher Main Business
Table 102. Danaher Latest Developments
Table 103. Medaysis Company Basic Information, Acute Myeloid Leukemia Biomarker Detection Manufacturing Base, Sales Area and Its Competitors
Table 104. Medaysis Company Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
Table 105. Medaysis Company Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Medaysis Company Main Business
Table 107. Medaysis Company Latest Developments
Table 108. NeoGenomics Laboratories Basic Information, Acute Myeloid Leukemia Biomarker Detection Manufacturing Base, Sales Area and Its Competitors
Table 109. NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
Table 110. NeoGenomics Laboratories Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. NeoGenomics Laboratories Main Business
Table 112. NeoGenomics Laboratories Latest Developments
Table 113. QIAGEN N.V. Basic Information, Acute Myeloid Leukemia Biomarker Detection Manufacturing Base, Sales Area and Its Competitors
Table 114. QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
Table 115. QIAGEN N.V. Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. QIAGEN N.V. Main Business
Table 117. QIAGEN N.V. Latest Developments
Table 118. Thermo Fisher Scientific, Inc. Basic Information, Acute Myeloid Leukemia Biomarker Detection Manufacturing Base, Sales Area and Its Competitors
Table 119. Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
Table 120. Thermo Fisher Scientific, Inc. Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Thermo Fisher Scientific, Inc. Main Business
Table 122. Thermo Fisher Scientific, Inc. Latest Developments
Table 123. GeneTex Basic Information, Acute Myeloid Leukemia Biomarker Detection Manufacturing Base, Sales Area and Its Competitors
Table 124. GeneTex Acute Myeloid Leukemia Biomarker Detection Product Portfolios and Specifications
Table 125. GeneTex Acute Myeloid Leukemia Biomarker Detection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. GeneTex Main Business
Table 127. GeneTex Latest Developments
List of Figures
Figure 1. Picture of Acute Myeloid Leukemia Biomarker Detection
Figure 2. Acute Myeloid Leukemia Biomarker Detection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Acute Myeloid Leukemia Biomarker Detection Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Acute Myeloid Leukemia Biomarker Detection Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Acute Myeloid Leukemia Biomarker Detection Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Next Generation Sequencing Technology
Figure 10. Product Picture of PCR Detection Technology
Figure 11. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Type in 2022
Figure 12. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Type (2018-2023)
Figure 13. Acute Myeloid Leukemia Biomarker Detection Consumed in Hospital
Figure 14. Global Acute Myeloid Leukemia Biomarker Detection Market: Hospital (2018-2023) & (K Units)
Figure 15. Acute Myeloid Leukemia Biomarker Detection Consumed in Research Institutions
Figure 16. Global Acute Myeloid Leukemia Biomarker Detection Market: Research Institutions (2018-2023) & (K Units)
Figure 17. Acute Myeloid Leukemia Biomarker Detection Consumed in Other
Figure 18. Global Acute Myeloid Leukemia Biomarker Detection Market: Other (2018-2023) & (K Units)
Figure 19. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Application (2022)
Figure 20. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Application in 2022
Figure 21. Acute Myeloid Leukemia Biomarker Detection Sales Market by Company in 2022 (K Units)
Figure 22. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Company in 2022
Figure 23. Acute Myeloid Leukemia Biomarker Detection Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Company in 2022
Figure 25. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Acute Myeloid Leukemia Biomarker Detection Sales 2018-2023 (K Units)
Figure 28. Americas Acute Myeloid Leukemia Biomarker Detection Revenue 2018-2023 ($ Millions)
Figure 29. APAC Acute Myeloid Leukemia Biomarker Detection Sales 2018-2023 (K Units)
Figure 30. APAC Acute Myeloid Leukemia Biomarker Detection Revenue 2018-2023 ($ Millions)
Figure 31. Europe Acute Myeloid Leukemia Biomarker Detection Sales 2018-2023 (K Units)
Figure 32. Europe Acute Myeloid Leukemia Biomarker Detection Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Revenue 2018-2023 ($ Millions)
Figure 35. Americas Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Country in 2022
Figure 36. Americas Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Country in 2022
Figure 37. Americas Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Type (2018-2023)
Figure 38. Americas Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Application (2018-2023)
Figure 39. United States Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Region in 2022
Figure 44. APAC Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Regions in 2022
Figure 45. APAC Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Type (2018-2023)
Figure 46. APAC Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Application (2018-2023)
Figure 47. China Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Country in 2022
Figure 55. Europe Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Country in 2022
Figure 56. Europe Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Type (2018-2023)
Figure 57. Europe Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Application (2018-2023)
Figure 58. Germany Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Acute Myeloid Leukemia Biomarker Detection Sales Market Share by Application (2018-2023)
Figure 67. Egypt Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Acute Myeloid Leukemia Biomarker Detection Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Acute Myeloid Leukemia Biomarker Detection in 2022
Figure 73. Manufacturing Process Analysis of Acute Myeloid Leukemia Biomarker Detection
Figure 74. Industry Chain Structure of Acute Myeloid Leukemia Biomarker Detection
Figure 75. Channels of Distribution
Figure 76. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Forecast by Region (2024-2029)
Figure 77. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Acute Myeloid Leukemia Biomarker Detection Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Acute Myeloid Leukemia Biomarker Detection Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の急性骨髄性白血病バイオマーカー検出市場予測 2023年-2029年] (コード：LP23DC10924)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の急性骨髄性白血病バイオマーカー検出市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の慢性骨髄性白血病治療市場2022年：錠剤、溶液、カプセル
  • 世界のMRDの検出市場予測 2023年-2029年
  • 世界の血液がん検出装置市場予測 2023年-2029年
  • 世界のウェスタンブロット検出市場予測 2023年-2029年
  • 世界のマイコプラズマ用迅速検出キット市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆